标题
Clinically Applicable Inhibitors Impacting Genome Stability
作者
关键词
-
出版物
MOLECULES
Volume 23, Issue 5, Pages 1166
出版商
MDPI AG
发表日期
2018-05-14
DOI
10.3390/molecules23051166
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Epigenetics in Cancer
- (2018) Richard L. Bennett et al. Annual Review of Pharmacology and Toxicology
- Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells
- (2018) Nigus Ambaye et al. BIOCHEMISTRY
- Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay
- (2018) Yakai Song et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells
- (2018) Dongliang Mo et al. CANCER LETTERS
- Once and only once: mechanisms of centriole duplication and their deregulation in disease
- (2018) Erich A. Nigg et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways
- (2018) Vivek Tripathi et al. Nature Communications
- Directing the use of DDR kinase inhibitors in cancer treatment
- (2017) Inger Brandsma et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells
- (2017) Alexander D. Rhys et al. JOURNAL OF CELL BIOLOGY
- Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation
- (2017) Zhen-Yu She et al. JOURNAL OF CELL SCIENCE
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- Rad52 Inverse Strand Exchange Drives RNA-Templated DNA Double-Strand Break Repair
- (2017) Olga M. Mazina et al. MOLECULAR CELL
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
- (2017) Andrew N. Blackford et al. MOLECULAR CELL
- Histone methylation and the DNA damage response
- (2017) Fade Gong et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Chidamide in the treatment of peripheral T-cell lymphoma
- (2017) Thomas Chan et al. OncoTargets and Therapy
- A comprehensive review of lysine-specific demethylase 1 and its roles in cancer
- (2017) Amir Hosseini et al. Epigenomics
- Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1
- (2017) Edward J. Morris et al. Nature Communications
- Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
- (2017) Inma M. Berenjeno et al. Nature Communications
- Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions
- (2017) Susan M. Domchek Cancer Discovery
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- (2017) Chantal Pauli et al. Cancer Discovery
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
- (2017) Simone Treiger Sredni et al. Oncotarget
- Exclusive destruction of mitotic spindles in human cancer cells
- (2017) Leonid Visochek et al. Oncotarget
- Advances in Precision Medicine: Tailoring Individualized Therapies
- (2017) Kyle Matchett et al. Cancers
- Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
- (2017) Peter McAnena et al. Cancers
- Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
- (2016) D. Boucher et al. ANNALS OF ONCOLOGY
- Novel Insights into the Roles of Rho Kinase in Cancer
- (2016) Lei Wei et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Synthesis and activity of benzimidazole-1,3-dioxide inhibitors of separase
- (2016) Ha T. Do et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization
- (2016) Gleb Konotop et al. CANCER RESEARCH
- Abstract 1658: M3814, a novel investigational DNA-PK inhibitor: enhancing the effect of fractionated radiotherapy leading to complete regression of tumors in mice
- (2016) Frank T. Zenke et al. CANCER RESEARCH
- Big Data–Led Cancer Research, Application, and Insights
- (2016) James A.L. Brown et al. CANCER RESEARCH
- Targeting NEK2 as a promising therapeutic approach for cancer treatment
- (2016) Yanfen Fang et al. CELL CYCLE
- RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
- (2016) Yajing Liu et al. CLINICAL CANCER RESEARCH
- SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV
- (2016) George E. Greco et al. DNA REPAIR
- Identifying high quality, potent and selective inhibitors of ATM kinase: Discovery of AZD0156
- (2016) B. Barlaam et al. EUROPEAN JOURNAL OF CANCER
- Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy
- (2016) Stephanie M Myers et al. Future Medicinal Chemistry
- WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells
- (2016) R. Moles et al. Journal of Hematology & Oncology
- KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
- (2016) Roman P. Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
- (2016) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
- (2016) Rosie Elizabeth Ann Gutteridge et al. MOLECULAR CANCER THERAPEUTICS
- The TIP60 Complex Regulates Bivalent Chromatin Recognition by 53BP1 through Direct H4K20me Binding and H2AK15 Acetylation
- (2016) Karine Jacquet et al. MOLECULAR CELL
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors
- (2016) Fei Huang et al. NUCLEIC ACIDS RESEARCH
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection
- (2016) Katherine Sullivan et al. PLoS One
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Regulation of Single-Strand Annealing and its Role in Genome Maintenance
- (2016) Ragini Bhargava et al. TRENDS IN GENETICS
- Insights into APC/C: from cellular function to diseases and therapeutics
- (2016) Zhuan Zhou et al. Cell Division
- Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8
- (2016) Russell A. Judge et al. ACS Medicinal Chemistry Letters
- TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy
- (2016) Yi-Chao Zheng et al. Epigenomics
- A CEP215–HSET complex links centrosomes with spindle poles and drives centrosome clustering in cancer
- (2016) Pavithra L. Chavali et al. Nature Communications
- Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
- (2016) Marta Di Martile et al. Oncotarget
- KIFC1: a promising chemotherapy target for cancer treatment?
- (2016) Yu-Xi Xiao et al. Oncotarget
- “Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors
- (2016) Lorena Incorvaia et al. Oncotarget
- Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
- (2016) Ines Lohse et al. Oncotarget
- MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
- (2016) Kathleen A. Bridges et al. Oncotarget
- Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer
- (2016) Fade Gong et al. PLoS Genetics
- Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
- (2016) Stephen Murata et al. Biomed Research International
- Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells
- (2016) Sarah R Hengel et al. eLife
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- Targeting DNA Replication Stress for Cancer Therapy
- (2016) Jun Zhang et al. Genes
- RecQ helicases and PARP1 team up in maintaining genome integrity
- (2015) Sebastian Veith et al. AGEING RESEARCH REVIEWS
- Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
- (2015) Y. Shi et al. ANNALS OF ONCOLOGY
- Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering
- (2015) Jeffrey W. Johannes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
- (2015) R. H. Wijdeven et al. CANCER RESEARCH
- Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers
- (2015) Gurushankar Chandramouly et al. CHEMISTRY & BIOLOGY
- DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
- (2015) Mrinal Srivastava et al. CHEMISTRY & BIOLOGY
- Centrosomes are multifunctional regulators of genome stability
- (2015) Dorothy A. Lerit et al. CHROMOSOME RESEARCH
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Chromatin perturbations during the DNA damage response in higher eukaryotes
- (2015) Christopher J. Bakkenist et al. DNA REPAIR
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors
- (2015) Jiewen Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer
- (2015) Kevin M Foote et al. Future Medicinal Chemistry
- Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression
- (2015) Laura O’Regan et al. JOURNAL OF CELL BIOLOGY
- Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
- (2015) Marwan Kwok et al. LANCET
- Mitoxantrone, More than Just Another Topoisomerase II Poison
- (2015) Benny J. Evison et al. MEDICINAL RESEARCH REVIEWS
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- Centrosome function and assembly in animal cells
- (2015) Paul T. Conduit et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- KATs in cancer: functions and therapies
- (2015) A Farria et al. ONCOGENE
- Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics
- (2015) Manu Lopus et al. Pharmacological Reports
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis
- (2015) Nicholas Jette et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit
- (2015) Jaeyoun Kim et al. Nature Communications
- Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
- (2015) M. R. Girotti et al. Cancer Discovery
- Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe
- (2015) Jingjing Li et al. Oncotarget
- Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
- (2015) Paula A. Coelho et al. Open Biology
- DNA Damage Response Factors from Diverse Pathways, Including DNA Crosslink Repair, Mediate Alternative End Joining
- (2015) Sean M. Howard et al. PLoS Genetics
- PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
- (2015) Shiv Kumar et al. Biomed Research International
- Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
- (2015) J M Gajer et al. Oncogenesis
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Identification of novel small molecule inhibitors of centrosome clustering in cancer cells
- (2015) Eiko Kawamura et al. Oncotarget
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
- (2014) F. Ciardiello et al. ANNALS OF ONCOLOGY
- Human RecQ Helicases in DNA Repair, Recombination, and Replication
- (2014) Deborah L. Croteau et al. Annual Review of Biochemistry
- Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
- (2014) Andrew J. Holland et al. CANCER CELL
- Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
- (2014) Jacqueline M. Mason et al. CANCER CELL
- Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors
- (2014) Ruth Plummer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors
- (2014) J. M. Mason et al. CANCER RESEARCH
- Partial inhibition of Cdk1 in G2phase overrides the SAC and decouples mitotic events
- (2014) Rachael A McCloy et al. CELL CYCLE
- Nucleosome Structure and Function
- (2014) Robert K. McGinty et al. CHEMICAL REVIEWS
- First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan-Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
- (2014) D. Sarker et al. CLINICAL CANCER RESEARCH
- Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
- (2014) Tahir Chohan et al. CURRENT MEDICINAL CHEMISTRY
- Alternative end-joining pathway(s): Bricolage at DNA breaks
- (2014) Philippe Frit et al. DNA REPAIR
- Bloom syndrome
- (2014) Harleen Arora et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
- (2014) Mohammad Hojjat-Farsangi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Excess centrosomes disrupt endothelial cell migration via centrosome scattering
- (2014) Erich J. Kushner et al. JOURNAL OF CELL BIOLOGY
- Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
- (2014) Anqi Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey
- (2014) Gaëlle Mariaule et al. MOLECULES
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress
- (2014) C-Y Wang et al. ONCOGENE
- Separate to operate: control of centrosome positioning and separation
- (2014) F. G. Agircan et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Causes and consequences of centrosome abnormalities in cancer
- (2014) S. A. Godinho et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts
- (2014) Fei Huang et al. PLoS One
- CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration
- (2014) Yuling Xi et al. OncoTargets and Therapy
- Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
- (2014) V Pannu et al. Cell Death & Disease
- Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer
- (2014) YING ZHU et al. Oncology Letters
- APC/C is an essential regulator of centrosome clustering
- (2014) Konstantinos Drosopoulos et al. Nature Communications
- Rational design and validation of a Tip60 histone acetyltransferase inhibitor
- (2014) Chunxia Gao et al. Scientific Reports
- Structure of Aurora B–INCENP in complex with barasertib reveals a potential transinhibitory mechanism
- (2014) Fabio Sessa et al. Acta Crystallographica Section F-Structural Biology Communications
- Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity
- (2014) Giovanna Ferrari-Amorotti et al. NEOPLASIA
- A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
- (2014) David A. Alagpulinsa et al. Frontiers in Oncology
- Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
- (2013) Hyungshin Yim ANTI-CANCER DRUGS
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
- (2013) Wojciech M. Ciszewski et al. BREAST CANCER RESEARCH AND TREATMENT
- Chromatin Remodeling at DNA Double-Strand Breaks
- (2013) Brendan D. Price et al. CELL
- Targeting an Achilles’ heel of cancer with a WRN helicase inhibitor
- (2013) Monika Aggarwal et al. CELL CYCLE
- Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response
- (2013) Martin Bennetzen et al. CELL CYCLE
- The BLM dissolvasome in DNA replication and repair
- (2013) Kelly A. Manthei et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Small Molecule Inhibitor of the BLM Helicase Modulates Chromosome Stability in Human Cells
- (2013) Giang Huong Nguyen et al. CHEMISTRY & BIOLOGY
- Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes
- (2013) Ciorsdaidh A. Watts et al. CHEMISTRY & BIOLOGY
- The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1-11
- (2013) Andreas S. Madsen et al. ChemMedChem
- Regulation of Autophosphorylation Controls PLK4 Self-Destruction and Centriole Number
- (2013) Inês Cunha-Ferreira et al. CURRENT BIOLOGY
- Supercoiling in DNA and chromatin
- (2013) Nick Gilbert et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
- (2013) Jiewen Zhu et al. EMBO Molecular Medicine
- PARP inhibitors: polypharmacology versus selective inhibition
- (2013) Torun Ekblad et al. FEBS Journal
- Analysis of the Activities of RAD54, a SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor
- (2013) Julianna S. Deakyne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity
- (2013) Kevin M. Foote et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- DNA Double-Strand Break Repair Pathway Choice Is Directed by Distinct MRE11 Nuclease Activities
- (2013) Atsushi Shibata et al. MOLECULAR CELL
- Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
- (2013) Georgia Velimezi et al. NATURE CELL BIOLOGY
- Histone lysine demethylases as targets for anticancer therapy
- (2013) Jonas W. Højfeldt et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of nucleosome dynamics by histone modifications
- (2013) Gabriel E Zentner et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption
- (2013) Xin Zhou et al. PLoS One
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
- (2013) Anna Vavrova et al. PLoS One
- Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
- (2013) L. N. Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone Modifications and DNA Double-Strand Break Repair after Exposure to Ionizing Radiations
- (2013) Clayton R. Hunt et al. RADIATION RESEARCH
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
- (2012) Mustafa Khasraw et al. BREAST
- Inhibiting homologous recombination for cancer therapy
- (2012) Sophia B. Chernikova et al. CANCER BIOLOGY & THERAPY
- GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
- (2012) M. S. Raab et al. CANCER RESEARCH
- Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression
- (2012) M. Takawa et al. CANCER RESEARCH
- PARPs and the DNA damage response
- (2012) F. G. Sousa et al. CARCINOGENESIS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
- (2012) Mrinal Srivastava et al. CELL
- C-NAP1 and rootletin restrain DNA damage-induced centriole splitting and facilitate ciliogenesis
- (2012) Pauline C. Conroy et al. CELL CYCLE
- Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances
- (2012) M. Conte et al. CLINICAL CANCER RESEARCH
- 118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2
- (2012) B. Carbain et al. EUROPEAN JOURNAL OF CANCER
- The centrosome as potential target for cancer therapy and prevention
- (2012) Nina Korzeniewski et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Clinical Overview of Centrosome Amplification in Human Cancers
- (2012) Jason Yongsheng Chan International Journal of Biological Sciences
- Breaking the ties that bind: New advances in centrosome biology
- (2012) Balca R. Mardin et al. JOURNAL OF CELL BIOLOGY
- US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
- (2012) Patricia Cortazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase
- (2012) Fei Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
- (2012) Larry H. Thompson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
- (2012) Brian Budke et al. NUCLEIC ACIDS RESEARCH
- PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks
- (2012) Jana Krietsch et al. NUCLEIC ACIDS RESEARCH
- RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination
- (2012) B H Lok et al. ONCOGENE
- Nahuoic Acid A Produced by a Streptomyces sp. Isolated From a Marine Sediment Is a Selective SAM-Competitive Inhibitor of the Histone Methyltransferase SETD8
- (2012) David E. Williams et al. ORGANIC LETTERS
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- The Centrosome in Cells and Organisms
- (2012) M. Bornens SCIENCE
- Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
- (2012) E Fokas et al. Cell Death & Disease
- The interrelationship between APC/C and Plk1 activities in centriole disengagement
- (2012) T. Hatano et al. Biology Open
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- (2011) Fei Huang et al. ACS Chemical Biology
- Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates
- (2011) Silviya D. Furdas et al. ARCHIV DER PHARMAZIE
- A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
- (2011) Stephen Jamieson et al. BIOCHEMICAL JOURNAL
- A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells
- (2011) Asher Castiel et al. BMC CANCER
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
- (2011) Michele Tavecchio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel pathway of centrosome amplification that does not require DNA lesions
- (2011) Masataka Tsuda et al. CANCER SCIENCE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment
- (2011) L. S. Kurtzberg et al. CLINICAL CANCER RESEARCH
- CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells
- (2011) D. Trisciuoglio et al. CLINICAL CANCER RESEARCH
- Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- Centrosome amplification in CHO and DT40 cells by inactivation of cyclin-dependent kinases
- (2011) Nathan Steere et al. Cytoskeleton
- 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site
- (2011) Massimo Ghizzoni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Update on aurora kinase targeted therapeutics in oncology
- (2011) Myke R Green et al. Expert Opinion on Drug Discovery
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Irreversible Nek2 Kinase Inhibitors with Cellular Activity
- (2011) Jeffrey C. Henise et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
- (2011) Yuan Yao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Homologous Recombination by DNA-Dependent Protein Kinase Requires Kinase Activity, Is Titratable, and Is Modulated by Autophosphorylation
- (2011) J. A. Neal et al. MOLECULAR AND CELLULAR BIOLOGY
- A Peek into the Complex Realm of Histone Phosphorylation
- (2011) T. Banerjee et al. MOLECULAR AND CELLULAR BIOLOGY
- PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
- (2011) J. Yuan et al. MOLECULAR CANCER THERAPEUTICS
- Centrosome clustering and chromosomal (in)stability: A matter of life and death
- (2011) Alwin Krämer et al. Molecular Oncology
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- The MRE11 complex: starting from the ends
- (2011) Travis H. Stracker et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression
- (2011) Mahesh Ramamoorthy et al. NUCLEIC ACIDS RESEARCH
- Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms
- (2011) A. Carreira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress
- (2011) M. Aggarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
- (2011) C.-C. Wu et al. SCIENCE
- Structural Basis of Substrate Methylation and Inhibition of SMYD2
- (2011) Andrew D. Ferguson et al. STRUCTURE
- Centrosomes and cilia in human disease
- (2011) Mónica Bettencourt-Dias et al. TRENDS IN GENETICS
- The RecQ DNA Helicases in DNA Repair
- (2010) Kara A. Bernstein et al. Annual Review of Genetics
- Synergistic antimicrotubule therapy for prostate cancer
- (2010) Vaishali Pannu et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
- (2010) Eusebio Manchado et al. CANCER CELL
- The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability
- (2010) Hyun-Ja Nam et al. CARCINOGENESIS
- APC/C-Cdh1
- (2010) Xinxian Qiao et al. CELL CYCLE
- A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering
- (2010) P Karna et al. CELL DEATH AND DIFFERENTIATION
- Centriole Reduplication during Prolonged Interphase Requires Procentriole Maturation Governed by Plk1
- (2010) Jadranka Lončarek et al. CURRENT BIOLOGY
- Rad54, the motor of homologous recombination
- (2010) Alexander V. Mazin et al. DNA REPAIR
- Inside HDAC with HDAC inhibitors
- (2010) Philippe Bertrand EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias
- (2010) A S Moore et al. LEUKEMIA
- In vivo efficacy of griseofulvin against multiple myeloma
- (2010) Young Kim et al. LEUKEMIA RESEARCH
- ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action
- (2010) G. C. Fletcher et al. MOLECULAR CANCER THERAPEUTICS
- PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
- (2010) Jitesh P. Jani et al. MOLECULAR CANCER THERAPEUTICS
- Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair
- (2010) Eva Petermann et al. MOLECULAR CELL
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells
- (2010) A B Fielding et al. ONCOGENE
- MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification
- (2010) J A L Brown et al. ONCOGENE
- Rad52 inactivation is synthetically lethal with BRCA2 deficiency
- (2010) Z. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- DNA ligase IV as a new molecular target for temozolomide
- (2009) Natsuko Kondo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- (2009) Rong Chen et al. BLOOD
- KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
- (2009) Y. Shiotsu et al. BLOOD
- A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
- (2009) Andrew J. Massey et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Epigallocatechin-3-Gallate, a Histone Acetyltransferase Inhibitor, Inhibits EBV-Induced B Lymphocyte Transformation via Suppression of RelA Acetylation
- (2009) K.-C. Choi et al. CANCER RESEARCH
- Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers
- (2009) R. Meyer et al. CLINICAL CANCER RESEARCH
- Polo Kinase and Separase Regulate the Mitotic Licensing of Centriole Duplication in Human Cells
- (2009) Meng-Fu Bryan Tsou et al. DEVELOPMENTAL CELL
- A histone code for the DNA damage response in mammalian cells?
- (2009) Armelle Corpet et al. EMBO JOURNAL
- Centriole separation in DNA damage-induced centrosome amplification
- (2009) Chiara Saladino et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin
- (2009) Kodihalli C. Ravindra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The SCFSlimbubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication
- (2009) Gregory C. Rogers et al. JOURNAL OF CELL BIOLOGY
- -Tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells
- (2009) R. Kuriyama et al. JOURNAL OF CELL SCIENCE
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine
- (2009) G.T.-J. Huang et al. JOURNAL OF DENTAL RESEARCH
- Synthesis and Structure−Activity Relationship of Griseofulvin Analogues as Inhibitors of Centrosomal Clustering in Cancer Cells
- (2009) Mads H. Rønnest et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functional Dynamics of Polo-Like Kinase 1 at the Centrosome
- (2009) K. Kishi et al. MOLECULAR AND CELLULAR BIOLOGY
- The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
- (2009) Y. Pommier et al. MOLECULAR CANCER THERAPEUTICS
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
- Nucleosome positioning and gene regulation: advances through genomics
- (2009) Cizhong Jiang et al. NATURE REVIEWS GENETICS
- Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells
- (2009) Emilie Rass et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
- (2009) H. Nishida et al. NUCLEIC ACIDS RESEARCH
- DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2
- (2009) E Bourke et al. ONCOGENE
- Centrosome function in cancer: guilty or innocent?
- (2009) Deborah Zyss et al. TRENDS IN CELL BIOLOGY
- Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60
- (2008) Jiang Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Transient Inhibition of ATM Kinase Is Sufficient to Enhance Cellular Sensitivity to Ionizing Radiation
- (2008) M. D. Rainey et al. CANCER RESEARCH
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
- Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications
- (2008) V. Sarli et al. CLINICAL CANCER RESEARCH
- The consequences of Rad51 overexpression for normal and tumor cells
- (2008) Hannah L. Klein DNA REPAIR
- Comparison of nonhomologous end joining and homologous recombination in human cells
- (2008) Z MAO et al. DNA REPAIR
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
- (2008) Aude Dupré et al. Nature Chemical Biology
- Genome instability: a mechanistic view of its causes and consequences
- (2008) Andrés Aguilera et al. NATURE REVIEWS GENETICS
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- A chemical compound that stimulates the human homologous recombination protein RAD51
- (2008) K. Jayathilaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings
- (2008) Mitch McVey et al. TRENDS IN GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now